BiolActis is dedicated to developing innovative biologics that will treat metabolic disorders. The company's R&D program aims to support excellent science with an ultimate view of improving healthcare. The program includes Clinical Trials which add significantly to our understanding of biological effects and behavioral mechanisms of MPMs. In the first phase, we conduct lengthy preclinical testing in order to confirm that MPMs have the anticipated safety profile before launching Clinical Trials thus limiting and mitigating the risks and costs of human testing. BiolActis also does extensive formulation work to produce a product that can be delivered to humans in different forms (capsules, powders, drinks, food and cream) in order to ensure compliance. The company carries out a series of Clinical Trials in human carefully supervised, approved by Regulatory Authorities and Ethics Committees, to evaluate each MPM, to determine how it acts and whether it is safe and effective in the target human population.
Ganeden is the first company to use lactic acid bacteria to consistently mitigate and prevent many common diseases. The enormous potential of Lactobacillus, Acidophilus, and other species of lactic acid producing bacteria (collectively, "LAB") to improve the quality and quantity of our lives has been known for almost 100 years. These bacteria theoretically aid in maintaining proper gastro-intestinal function and in combating a variety of infectious and non-pathogenic disorders and diseases. Ganeden has been able to overcome the manufacturing, stability, and delivery challenges that are inherent in LAB with our own patented variety and use this breakthrough to develop effective treatments for a number of conditions. To date, the company has established patent protection on over 100 separate products. Central to our founding core values, the company and its employees work every single day to earn the trust and confidence of the people who buy Ganeden products. Our standard is to only offer products that dramatically improve the quality of peoples' lives.
http://www.pilottherapeutics.com
Pilot utilizes scientific innovation and clinical testing approaches to produce a pipeline of human and veterinary medical food products aimed at huge markets and capable of rapidly moving into the marketplace. Through these approaches, Pilot has created a robust pipeline of medical food products for inflammatory diseases such as asthma, allergies, arthritis, diabetes, and heart disease in humans and animals. The company leverages its extensive market-led innovation expertise to take high potential technologies from concept to validated product platform with full understanding of the consumer experience, differentiating benefits, product, packaging, regulatory approach and supply chain. The company primarily looks to bring these validated product platforms to the U.S. and global markets through strategic partnerships with well-positioned market leaders seeking to establish new, innovative growth platforms. Pilot's first medical food product is a proprietary fatty acid combination for the dietary management of allergies and asthma. This product was developed and tested by Pilot in five clinical trials to validate safety and efficacy and licensed to Efficas, a Colorado-based consumer focused health-science and technology company (http://www.efficas.com).
About The BioBalance Corporation BioBalance, a development stage specialty pharmaceutical company, is focused on the development of patented biotherapeutic agents for gastrointestinal disorders that are poorly addressed by current therapies via accelerated regulatory pathways. These disorders include pouchitis, Irritable Bowel Syndrome (IBS), inflammatory bowel disease and diarrhea caused by antibiotics, chemotherapy or AIDS. On January 2, 2003, New York Health Care and BioBalance completed a business combination accounted for as a "reverse acquisition," in which BioBalance became a wholly owned subsidiary of the Company. The Company's common stock trades on the OTC Bulletin Board under the symbol BBAL.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory